Rapid Micro Biosystems, Inc.
RPID
$2.22
$0.020.91%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 19.74% | 16.63% | 22.57% | 28.36% | 24.57% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.74% | 16.63% | 22.57% | 28.36% | 24.57% |
| Cost of Revenue | 15.55% | 2.68% | -0.78% | -1.72% | 0.56% |
| Gross Profit | 1,060.55% | 286.69% | 164.92% | 134.84% | 98.01% |
| SG&A Expenses | -1.07% | -5.88% | -6.15% | -6.69% | -7.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.86% | -2.71% | -3.33% | -2.67% | -1.41% |
| Operating Income | 5.06% | 12.47% | 15.12% | 15.47% | 11.75% |
| Income Before Tax | -0.46% | 8.44% | 12.57% | 13.63% | 10.62% |
| Income Tax Expenses | 81.82% | -56.41% | -38.89% | -3.70% | -29.03% |
| Earnings from Continuing Operations | -0.50% | 8.48% | 12.59% | 13.63% | 10.63% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -0.50% | 8.48% | 12.59% | 13.63% | 10.63% |
| EBIT | 5.06% | 12.47% | 15.12% | 15.47% | 11.75% |
| EBITDA | 4.93% | 13.11% | 16.13% | 16.58% | 12.65% |
| EPS Basic | 1.76% | 10.45% | 14.12% | 14.87% | 11.74% |
| Normalized Basic EPS | 1.81% | 10.40% | 14.07% | 14.86% | 11.71% |
| EPS Diluted | 1.76% | 10.45% | 14.12% | 14.87% | 11.74% |
| Normalized Diluted EPS | 1.81% | 10.40% | 14.07% | 14.86% | 11.71% |
| Average Basic Shares Outstanding | 2.25% | 2.13% | 1.73% | 1.46% | 1.28% |
| Average Diluted Shares Outstanding | 2.25% | 2.13% | 1.73% | 1.46% | 1.28% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |